Phenazopyridine Hydrochloride
- Product NDC
- 68788-8668
- Requested package NDC
- 68788-8668-2
- 11-digit product format
- 687888668
- Labeler code
- 68788
- Product ID
- 68788-8668_80b0692c-612b-4724-92bc-9dd2e30501fe
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Phenazopyridine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2024-05-20
- Substance
- PHENAZOPYRIDINE HYDROCHLORIDE
- Active strength
- 100 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Phenazopyridine Hydrochloride
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PHENAZOPYRIDINE HYDROCHLORIDE | 100 mg/1 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68788-8668-1 | Phenazopyridine Hydrochloride | 15 in 1 BOTTLE | TABLET | 15 | | 2 |
| 68788-8668-6 | Phenazopyridine Hydrochloride | 6 in 1 BOTTLE | TABLET | 6 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68788-8668 | PHENAZOPYRIDINE HYDROCHLORIDE TABLET [PREFERRED PHARMACEUTICALS INC.] | 1 | Current NDC, 2 package rows | 20240524_ce702be2-eec2-4346-965e-f1f6ba342fc9.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 68788-8668-2 | 68788866802 | 12 TABLET in 1 BOTTLE (68788-8668-2) | 12 tablet | 2024-05-20 | No | No | Current |